Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01026753|
Recruitment Status : Completed
First Posted : December 4, 2009
Last Update Posted : June 11, 2013
|Condition or disease||Intervention/treatment||Phase|
|Colorectal Cancer||Behavioral: Refrigerator Magnet||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||2395 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba|
|Study Start Date :||August 2010|
|Actual Primary Completion Date :||July 2011|
|Actual Study Completion Date :||December 2011|
No Intervention: FOBT by laboratory requisition or directly by PCP
The family physician indicates fecal occult blood test on the patient's laboratory requisition (i.e. the patient receives the fecal occult blood test at the lab) or provides the patient with an FOBT kit.
Experimental: FOBT by lab req. or directly from PCP + study magnet
The family physician indicates fecal occult blood test on the patient's laboratory requisition (i.e. the patient receives the fecal occult blood test at the lab) or provides the patient with an FOBT kit. The family physician provides each patient with a study magnet containing a PHCC telephone number and study specific website address.
Behavioral: Refrigerator Magnet
The refrigerator magnet contains a telephone number for a Provincial Health Contact Centre and a URL for a colorectal cancer Website that patients can access to learn more about colorectal cancer, screening and the fecal occult blood test. Patients can also have their questions answered.
- Fecal Occult Blood Test (FOBT) completion rate [ Time Frame: 4 months ]
- The most common patient questions and comments about colorectal cancer, screening, and the fecal occult blood test during the intervention(s). A patient and primary care provider survey. [ Time Frame: 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01026753
|University of Manitoba|
|Winnipeg, Manitoba, Canada, R3E 0W3|
|Principal Investigator:||Alan Katz, MBChB, CCFP, MSc||University of Manitoba|
|Study Director:||Kathleen M Clouston, Ph.D.||University of Manitoba|